These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1731018)

  • 21. Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease.
    Suzuki Y
    Brain Dev; 2013 Jun; 35(6):515-23. PubMed ID: 23290321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Substituted 5-amino-1-hydroxymethyl-cyclopentanetriols: A new family of activity promotors for a G
    Schalli M; Tysoe C; Fischer R; Pabst BM; Thonhofer M; Paschke E; Rappitsch T; Stütz AE; Tschernutter M; Windischhofer W; Withers SG
    Carbohydr Res; 2017 Apr; 443-444():15-22. PubMed ID: 28319682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fluorescent probe for GM1 gangliosidosis related β-galactosidase: N-(dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol.
    Fröhlich RF; Fantur K; Furneaux RH; Paschke E; Stütz AE; Wicki J; Withers SG; Wrodnigg TM
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6872-5. PubMed ID: 21974950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
    Kwak JE; Son MY; Son YS; Son MJ; Cho YS
    Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction of acid beta-galactosidase deficiency in GM1 gangliosidosis human fibroblasts by retrovirus vector-mediated gene transfer: higher efficiency of release and cross-correction by the murine enzyme.
    Sena-Esteves M; Camp SM; Alroy J; Breakefield XO; Kaye EM
    Hum Gene Ther; 2000 Mar; 11(5):715-27. PubMed ID: 10757351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non-neurological characteristics of Gm1 gangliosidosis type 1. A report of three cases within the same family].
    Bernal Ferrer A; Martí Barranco E; Tomás Vila M; Oltra Benavent M; Martinez Martinez J; Chabás A
    An Esp Pediatr; 1999 May; 50(5):513-6. PubMed ID: 10394196
    [No Abstract]   [Full Text] [Related]  

  • 27. The potential action of galactose as a "chemical chaperone": increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient.
    Caciotti A; Donati MA; d'Azzo A; Salvioli R; Guerrini R; Zammarchi E; Morrone A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):160-4. PubMed ID: 18571950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GM1 gangliosidosis in adults: clinical and molecular analysis of 16 Japanese patients.
    Yoshida K; Oshima A; Sakuraba H; Nakano T; Yanagisawa N; Inui K; Okada S; Uyama E; Namba R; Kondo K
    Ann Neurol; 1992 Mar; 31(3):328-32. PubMed ID: 1353343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelination arrest demonstrated using magnetic resonance imaging in a child with type I GM1 gangliosidosis.
    Shen WC; Tsai FJ; Tsai CH
    J Formos Med Assoc; 1998 Apr; 97(4):296-9. PubMed ID: 9585685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis.
    Aguilar-Moncayo M; Takai T; Higaki K; Mena-Barragán T; Hirano Y; Yura K; Li L; Yu Y; Ninomiya H; García-Moreno MI; Ishii S; Sakakibara Y; Ohno K; Nanba E; Ortiz Mellet C; García Fernández JM; Suzuki Y
    Chem Commun (Camb); 2012 Jul; 48(52):6514-6. PubMed ID: 22618082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.
    Callahan JW
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):85-103. PubMed ID: 10571006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotypic and phenotypic characterization of Brazilian patients with GM1 gangliosidosis.
    Sperb F; Vairo F; Burin M; Mayer FQ; Matte U; Giugliani R
    Gene; 2013 Jan; 512(1):113-6. PubMed ID: 23046582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging findings and novel mutations in GM1 gangliosidosis.
    Gururaj A; Sztriha L; Hertecant J; Johansen JG; Georgiou T; Campos Y; Drousiotou A; d'Azzo A
    J Child Neurol; 2005 Jan; 20(1):57-60. PubMed ID: 15791924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.
    Satoh H; Yamato O; Asano T; Yonemura M; Yamauchi T; Hasegawa D; Orima H; Arai T; Yamasaki M; Maede Y
    Brain Res; 2007 Feb; 1133(1):200-8. PubMed ID: 17196562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candidate molecules for chemical chaperone therapy of GM1-gangliosidosis.
    Higaki K; Ninomiya H; Suzuki Y; Nanba E
    Future Med Chem; 2013 Sep; 5(13):1551-8. PubMed ID: 24024947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benign transient hyperphosphatasemia in children with leukemia and lymphoma.
    Massey GV; Dunn NL; Heckel JL; Chan JC; Russell EC
    Clin Pediatr (Phila); 1996 Oct; 35(10):501-4. PubMed ID: 8902328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Alkaline phosphatase isoenzymes in a case of transient hyperphosphatasemia].
    Botti C; Di Nillo M; Bernardi F; Mellini M; Biani D; Rizzo L
    Pediatr Med Chir; 1995; 17(6):587-9. PubMed ID: 8668599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 1 GM1 gangliosidosis with basal ganglia calcification: a case report.
    Chen CC; Chiu PC; Shieh KS
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jan; 62(1):40-5. PubMed ID: 10063711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Observations on the activity of alkaline phosphatase in neutrophilic granulocytes in the bone marrow of 100 normal individuals inhabiting high altitude districts (author's transl)].
    Jei NY
    Zhonghua Nei Ke Za Zhi; 1980 Nov; 19(6):456-7. PubMed ID: 7297266
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
    Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y
    J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.